BNP Paribas Financial Markets
XTNT icon

BNP Paribas Financial Markets’s Xtant Medical Holdings XTNT Stock Holding History

BNP Paribas Financial Markets’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10
Closed -$820 – 4302
2014
Q2 		$820 Hold
10
– – ﹤0.01% 3480
2014
Q1 		$844 Hold
10
– – ﹤0.01% 2914
2013
Q4 		$603 Buy
+10
New +$639 ﹤0.01% 3918

Other funds holding XTNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets's XTNT Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of Xtant Medical Holdings (XTNT) in Q3 2014, closing a stake of 10 shares — an estimated $820 sold.

BNP Paribas Financial Markets first reported a position in XTNT in Q4 2013 and held it in 3 quarters. The position peaked at $844 in Q1 2014. 20 funds tracked by Wall St. Rank hold XTNT as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining Xtant Medical Holdings position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 10 Xtant Medical Holdings shares in Q3 2014, an estimated $820.
  • BNP Paribas Financial Markets first reported a position in Xtant Medical Holdings in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Xtant Medical Holdings position peaked at $844 in Q1 2014.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.